- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
The rollout extends to over-65s and at-risk groups, as England and Wales say they met their target.
It includes people with chronic heart disease, liver disease, kidney disease, diabetes, severe lung conditions, severe learning disabilities and mental health conditions such as schizophrenia and bipolar disorder.
- Advertisement -